Skip to main content
ASPIC
pt
en
Search form
Search
Toggle navigation
Home
About ASPIC
Become a member
News
Meetings
Jobs
For patients
Partners
Contacts
Home
About ASPIC
Mission
Statutes and Regulations
Committees
Reports
Make a donation
Aspic Ambassadors
Become a member
Benefits of membership
Become a member
honorary members
News
Meetings
Jobs
For patients
Partners
Contacts
Where we are
find your way to us
Associação Portuguesa de Investigação em Cancro
Send information
Recetor de andrógeno
send to a friend
share this
O potencial benefício clínico do recetor de androgénio (AR) como alvo terapêutico em células de cancro de mama ER+ tratadas com Exemestano
<
Back to list
Tags:
Recetor de andrógeno
cancro da mama
Cristina Amaral
Exemestano
Georgina Correia-da-Silva
Natércia Teixeira
ASPIC